Texas Unclaimed Property Lawyer Represents Families, Heirs, and Beneficiaries Claim Unclaimed Property by Texas Unclaimed Property Lawyer Jason S. Coomer

Texas Estate Unclaimed Property Lawyer Represents Families, Heirs, and Beneficiaries Claim Life Insurance, Estate Property, Inheritance, Bank Accounts, Retirement Funds, and Other Unclaimed Property by Texas Unclaimed Property Lawyer Jason Coomer

The State of Texas is currently safekeeping over $2 billion in unclaimed property.  These assets include a vast amount of family inheritance that has been lost or unclaimed because of a person's death or incapacity.  This property often will require a probate administration and the assistance of a Texas probate lawyer to free help free the unclaimed property.

For more information on collection of unclaimed property, please feel free to send an e-mail message to Texas Unclaimed Property Lawyer, Jason Coomer.

Families Living Outside of Texas Can Often Hire a Texas Texas Estate Unclaimed Property Lawyer to Handle Most of the Probate Process to Claim Inheritance and Texas Unclaimed Property

It is becoming more common for family members not living close in proximity to a recently deceased relative to not know what is in the decedent's estate and not know how to clear title to their family members assets.  This distance and lack of knowledge will often result in inheritance including mineral interests, life insurance, bank accounts, retirement funds, houses, and royalties being lost to unclaimed property.  In instances where there are significant assets in a person's estate, it can often be a good idea to locate a local Texas probate attorney that can assist in collecting the estate assets and moving the estate including real estate, mineral interests, bank accounts, and houses through the probate process. 

Communication Can Often Help Prevent the Loss Of Inheritance

In our modern society when families can be spread out throughout the World and significant wealth can be lost, stolen, or forgotten.  It is often a good idea to keep a safety deposit box with an inventory of all your assets and have a person or people that you trust that can get access to your safety deposit box should something happen to you.  Though many people prefer to avoid envisioning a time when their may die or become incapacitated, it is often important to make plans prior to a crisis arises for you or your family.

Texas Estate Unclaimed Property Lawyer Represents Families, Heirs, and Beneficiaries Claim Life Insurance, Estate Property, Inheritance, Bank Accounts, Retirement Funds, and Other Unclaimed Property by Texas Unclaimed Property Lawyer Jason Coomer

For more information on collection of unclaimed property including Texas mineral interests, Texas royalty income, Texas unclaimed property, Texas bank accounts, Texas life insurance policies, and other Texas estate property, please feel free to follow this link to Claiming Texas Estate and Probate Unclaimed Property, Mineral Interests, and Royalty Information.  

Pancreatic Cancer and Diabetes Drugs: Large Profits Encourage Drug Companies To Sell Dangerous Diabetes Drugs by Pancreatic Cancer Diabetes Drug Lawyer

Pancreatic Cancer and Diabetes Drugs: The Diabetes Drug Market is Over $40 Billion Each Year and Growing Rapidly Encouraging Drug Companies To Push Dangerous Diabetes Drugs To Increase Profits by Pancreatic Cancer Diabetes Drug Lawyer Jason S. Coomer

More than 300 million people worldwide suffer from diabetes, including about 30 million Americans.  In 2010, the global prevalence of diabetes was estimated to have reached 285 million and is predicted to reach 438 million by 2030. The corresponding figures for North America were 37.4 million in 2010 and 53.2 million by 2030 and in Europe 55.2 million in 2010 and 66.2 million in 2030.  The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018. As such, several drug companies are pushing hard to capture a large part of the profitable diabetes drug market regardless as to the safety of their drug.

Pancreatic Cancer and Diabetes Drugs: Several Different Types of Diabetes Drugs Have Been Shown To Cause An Increased Risk of Pancreatic Cancer

Recent scientific studies have shown that several diabetes drugs may cause an increased risk of pancreatic cancer.  People that are taking Onglyza, Tradjenta, Bydureon, Oseni, Byetta, Victoza, Januvia, or Janumet should be aware of the potential dangers of these drugs and should discuss the potential dangers of these drugs with their physician.  

If you have lost a loved one from Pancreatic Cancer who was taking a diabetes drug or you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible.  Attorneys are in the process of filing and reviewing lawsuits where a person has developed pancreatic cancer after taking Onglyza, Tradjenta, Bydureon, Oseni, Byetta, Victoza, Januvia, and/or Janumet. For more information on this topic, please feel free to contact Diabetic Drug Pancreatic Cancer Lawyer, Jason S. Coomer or go to the following webpage: Pancreatic Cancer Lawsuit Information.

Pancreatic Cancer Detection: Understanding and Identifying Symptoms of Pancreatic Cancer Can Be Important In Early Detection and Treatment of Pancreatic Cancer Resulting in Higher Pancreatic Cancer Survival Rates

Symptoms of pancreatic cancer can include: dark urine and clay-colored stools, fatigue and weakness, jaundice (a yellow color in the skin, mucus membranes, or eyes), loss of appetite and weight loss, nausea and vomiting, pain or discomfort in the upper part of the belly or abdomen, back pain, blood clots, diarrhea, and indigestion.

Pancreatic cancer is often not detected early on and is often advanced when it is first found.  As such, ninety-five percent of the people diagnosed with this cancer will not be alive 5 years later.  Some patients have pancreatic cancer that can be surgically removed are cured. However, in more than 80% of patients the tumor has already spread and cannot be completely removed at the time of diagnosis.  In the few cases where pancreatic tumors can be removed by surgery. The standard surgical procedure to remove pancreatic tumors is called a Whipple procedure (pancreatoduodenectomy or pancreaticoduodenectomy). This surgery should be done by an experienced surgeon and at a medical center that performs the procedure often. Some studies suggest that the Whipple procedure is best performed at hospitals that do more than five of these surgeries per year.

When the tumor has not spread out of the pancreas, but cannot be removed, radiation therapy and chemotherapy together may be recommended. When the tumor has spread (metastasized) to other organs such as the liver, chemotherapy alone is usually used. The standard chemotherapy drug is gemcitabine, but other drugs may be used. Gemcitabine can help about 25% of patients.

Patients whose tumor cannot be totally removed, but who have a blockage of the tubes that transport bile (biliary obstruction) must have that blockage relieved. There are two approaches including surgery and placement of a tiny metal tube (biliary stent) during ERCP.

Managing pain and other symptoms is an important part of treating advanced pancreatic cancer. Palliative care tams and hospice can help with pain and symptom management, and provide psychological support for patients and their families during the illness.

Texas Real Estate Partitions Are Often Needed When Families Inherit Real Property by Texas Real Estate Partition Lawyer Jason S. Coomer

Texas Real Estate Partitions Are Often Needed When Families Inherit Real Property by Texas Real Estate Partition Lawyer Jason S. Coomer

Texas Real Estate Partitions are often needed when heirs, family members, and beneficiaries inherit Texas real estate and want to partition or divide the inherited real estate.  A Texas real partition lawsuit can force the division or sale of inherited real estate including: commercial buildings, farms, mineral interests, lake houses, ranches, condominiums, houses, or commercial property.  
 

For information on Texas Inheritance Real Estate Partition Lawsuits or Texas Probate Real Estate Forced Sale Lawsuits, please feel free to go to the follow webpage: Texas Real Estate Partition Lawsuit Information or please send an e-mail message to Texas Real Estate Partition Attorney Jason S. Coomer.  

What is a Texas Real Estate Partition (Partition in Kind v. Partition by Sale)

 

In simple terms a Texas real estate partition divides Texas real estate interests.  When real estate is a large tract of land and owned by several different owners, a partition may be done as a partition in kind by dividing the land into sections so each owner ends up with a separate, but equal portion of the real estate.  This partition process can be simple or complex depending on several factors including the type of real property that is being divided and the determination of the owners to litigate.  The goal in a partition is to make sure that the division or partition is fair among the owners.  

However, when the real estate is a house, building, or other unique real estate a partition may be impractical or impossible.  Some real property just cannot be divided by the owners including a house or building.  In dealing with such unique property, the partition may need to be a partition by sale.  A partition in kind is a division of the property itself, whereas partition by sale constitutes a forced sale of the land, followed by division of the profits thus realized among the owners of the real estate.  A common example of the partition by sale occurs when more than one person inherits a house or building.

When Does a Texas Real Estate Partition Lawsuit Typically Occur?

 

Texas real estate partition lawsuits commonly occur after heirs or beneficiaries inherit a house or other real estate.  In this situation, it is common for the heirs or beneficiaries to not be able to agree to whether to keep or sell the property.  In some instances all or some of the heirs or beneficiaries live out of state, or have their own homes and have no need for another house or additional real estate.  In other instances some of the heir or beneficiaries need cash and want to sell their interest.  In still other situations, one or more of the heirs or beneficiaries do not want to sell a family house or family real property, but cannot afford to purchase the other heir's interest in the house or other property.  In many of these situations, a real estate partition by sale may be necessary to sell or divide the inherited property. 

Defective Spinal Stimulators: Medtronic Stimulators and Boston Scientific Stimulators May Malfunction by Defective Spinal Stimulator Lawyer Jason S. Coomer

Defective Spinal Stimulators: Implantable Neurostimulation Systems Including Medtronic Spinal Stimulators and Boston Scientific Spinal Stimulators May Malfunction Requiring Removal or Replacement of the Device by Defective Spinal Stimulator Lawyer Jason S. Coomer

Defective Implantable Neurostimulation Systems have caused many people to suffer severe shocks, severe pain, and other significant health problems. Persons with or thinking about receiving a Boston Scientific spinal stimulator or Medtronic stimulator should speak with their health care provider about the potential health risks of having a spinal stimulator implanted in them as well as make sure that the device is being used for an FDA approved indication.

Persons that have experienced malfunctioning batteries and other problems with an implanted spinal stimulator, should consult their health care provider and make sure that any adverse health events from the implanted spinal stimulator are reported to the FDA. For more information on defective spinal stimulator lawsuits, please go to the following web page: Defective Implantable Neurostimulation  System Lawsuit Information or use our submission form to send an inquiry to Defective Spinal Stimulator Lawyer Jason Coomer.

FDA Action on Spinal Stimulators

The U.S. Food and Drug Administration (“FDA”) issues warning letters when it finds certain problems that it wants a company to fix.  In a letter dated July 17, 2012, the FDA issued a warning letter related to Medtronic’s process for handling complaints and stated that regulatory action might ensue should the manufacturer fail to address the agency’s request to take action.

The FDA is seeking information from persons that have experienced the following symptoms from stimulators:

• Severe irritation and  burning at the battery site
• An inability to control the stimulator (resulting in unwelcome jolts, pain, or temporary paralysis)
• Severe burns while recharging the battery
• Premature battery depletion
• Bladder problems
• Increased numbness
• Lead migration and broken anchors
• Partial paralysis

Removal of Defective Spinal Stimulators May Be The Basis for a Lawsuit 

In most cases, when a stimulator is found to be defective it must be removed. This surgery can be both costly and cause its own complications. Not only is there always a risk of infection with every surgery, but because the removal of a stimulator requires navigating delicate nerves in the spine, it is possible that nerves can be nicked or otherwise damages during the procedure leading to symptoms such as weakness, pain, or numbness in the body. In some cases, removal of the simulator can result in a leakage of spinal fluid from the epidural space, leading to severe and long-lasting headaches or feelings of fatigue which may heal on its own or may require its own surgery to repair.

Implantable Spinal-Devices Are a Multi-billion Dollar Industry and Two of Leading Manufacturers In the Industry Are Medtronic and Boston Scientific

Implantable Neurostimulation Systems and other spinal-devices are a huge business for the medical implant device industry.  The global market for spinal-devices is currently over $ 3 billion per year and is expected to increase to over $5 billion per year by 2018.

Neurostimulators have been used for a variety of types of chronic back pain situations including heriniated disks, postlaminectomy paid, Complex Reginal Pay Syndrome, unsuccessful disk surgery, Degenerative Disk Disease, and Failed Back Syndrome. The Medtronic implantable neurostimulation system is indicated for spinal cord stimulation (SCS) as an aid in the management of chronic, intractable pain of the trunk and/or limbs—including unilateral or bilateral pain associated with several different conditions.   Unfortunately, because of the profits to be made from implanting a spinal stimulator, many people have received spinal stimulators for off-label or non-approved indications.  

Medical professionals that are aware of significant off-label use of spinal stimulators are encouraged to properly report any Medicare fraud or Medicaid fraud that may be occurring.  Please feel free to go to the following web page for information on Qui Tam Whistleblower Reward Lawsuits and Reporting Medicare Fraud.

Spinal Stimulator Lawsuit Information

In reviewing potential failed back surgery implant lawsuits, it is important to obtain copies of your medical records and to determine if the implantable neurostimulation system was properly implanted by the spinal surgeon or if the spinal stimulator was defective.  If the spinal stimulator was defective and has/had to be removed, it is important that the defective device is kept as potential evidence.  For more information on this topic, please feel free to go to the following web page, Failed Back Surgery and Defective Implantable Neurostimulation System Lawsuits.

Failed Transvaginal Mesh Surgery: Failed Transvaginal Mesh Surgery Can Cause Serious Health Problems From Mesh Contraction and Mesh Erosion in Women by Texas Failed Transvaginal Mesh Surgery Lawyer Jason S. Coomer

Health Warning Failed Transvaginal Mesh Surgery: Surgeries That Use Transvaginal Mesh Can Result In Significant Health Issues From Mesh Contraction and Mesh Erosion by Texas Failed Transvaginal Mesh Surgery Lawyer Jason S. Coomer

Thousands of women, who have had transvaginal mesh implanted in them during surgery, are at an increased risk of suffering significant health problems from failed transvaginal mesh surgery.  These health problems can be caused by mesh erosion, mesh deterioration, and mesh contraction and can include recurrence of prolapse and/or incontinence; bowel perforation; bladder perforation; blood vessel perforation; neurological problems; erosion of the mesh through vagina infection; urinary problems; and vaginal epithelium.  These health issues can often require multiple surgeries to repair or cause permanent health problems. 

If you or a loved one has suffered significant health problems from a failed transvaginal mesh

surgery, it is important to seek immediate medical attention.  For more information on failed tranvaginal mesh surgery lawsuits, failed pelvic organ prolapse (POP) surgery lawsuits, or failed stress urinary incontinence (SUI) surgery lawsuits, please feel free to contact Texas Failed Transvaginal Mesh Surgery Lawyer, Jason Coomer, via e-mail message or go to the following webpage: Transvaginal Mesh Surgery Lawsuit Information.

Texas Failed Transvaginal Mesh Surgery Lawsuit Information

On February 25, 2013, a jury awarded $3.35 million to a woman who suffered a failed transvaginal mesh surgery.  The failed transvaginal mesh surgery caused the woman to suffer erosion, scar tissue, inflammation and neurologic compromise.  The woman had to seek significant medical treatment including having to endure 18 operations to repair the damage caused by the failed transvaginal mesh.  This case in one of the first transvaginal mesh lawsuits to reach a jury and many more failed transvaginal mesh lawsuits are currently pending and are expected to be filed.

 Transvaginal Mesh FDA Safety Communications and Actions

On July 13, 2011, the United States Food and Drug Administration released the below FDA Safety Communication update regarding Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse.  This FDA Safety Communication and other FDA Actions were intended to provide adequate safety warnings to women and their health care providers regarding the potential health risk of transvaginal mesh.  Women considering transvaginal mesh surgery and their health care providers should be aware of these potential health risks.

Device:

Surgical mesh is a medical device that is generally used to repair weakened or damaged tissue. It is made from porous absorbable or non-absorbable synthetic material or absorbable biologic material. In urogynecologic procedures, surgical mesh is permanently implanted to reinforce the weakened vaginal wall to repair pelvic organ prolapse or to support the urethra to treat urinary incontinence.

Background:

Pelvic organ prolapse (POP) occurs when the tissues that hold the pelvic organs in place become weak or stretched. Thirty to fifty percent of women may experience POP in their lifetime with 2 percent developing symptoms. When POP happens, the organs bulge (prolapse) into the vagina and sometimes prolapse past the vaginal opening. More than one pelvic organ can prolapse at the same time. Organs that can be involved in POP include the bladder, the uterus, the rectum, the top of the vagina (vaginal apex) after a hysterectomy, and the bowel.

Mesh Contraction and Mesh Erosion:

The FDA’s literature review found that erosion of mesh through the vagina is the most common and consistently reported mesh-related complication from transvaginal POP surgeries using mesh. Mesh erosion can require multiple surgeries to repair and can be debilitating for some women. In some cases, even multiple surgeries will not resolve the complication.

Mesh contraction (shrinkage) is a previously unidentified risk of transvaginal POP repair with mesh that has been reported in the published scientific literature and in adverse event reports to the FDA since the Oct. 20, 2008 FDA Public Health Notification. Reports in the literature associate mesh contraction with vaginal shortening, vaginal tightening and vaginal pain.

Both mesh erosion and mesh contraction may lead to severe pelvic pain, painful sexual intercourse or an inability to engage in sexual intercourse.

 Texas Failed Transvaginal Mesh Surgery Lawsuit Information

If you or a loved one has suffered from a failed transvaginal mesh surgery, it is important to seek immediate medical attention.  For information on a failed transvaginal mesh surgery lawsuits, please feel free to contact Texas Failed Transvaginal Surgery Lawyer, Jason Coomer, via e-mail message or go to the following web page on Failed Transvaginal Surgery Lawsuit Information

Texas Oil Business Fraud Lawyer: The Booming Texas Oil Business Has Created Opportunities Where Fraud and Illegal Acts Can Produce Large Profits by Texas Oil Business Fraud Lawyer Jason S. Coomer

Texas Oil Business Fraud Lawyer:  The Texas Eagleford Shale and Booming Oil Business Has Created An Environment Where Fraudulent and Illegal Actions Can Create Large Profits For Fraudulent Businesses and Individuals by Texas Oil Business Fraud Lawyer Jason S. Coomer

The oil business in Texas is booming making numerous oil companies, land owners, and investors extremely wealthy.  However, where there is significant money and wealth to be had, there are also people that will attempt to fraudulently take assets, breach fiduciary duties to enrich themselves, breach contracts and partnership agreements, forge documents, and use other illegal means to take large amounts of money.  When this happens, it is essential to obtain evidence of the fraud or other illegal activity as well as the damages or losses that have been suffered, and confidentially speak with a Texas Oil Business Fraud Lawyer.

In reviewing this information a Texas oil business fraud lawyer can often determine if there is a good case to recover the losses and can sometimes take a Texas oil business fraud lawsuit on a contingent contract.  For more information on this topic including potential causes of action in Texas oil business fraud litigation, please read below or  feel free to contact Texas Oil Business Fraud Lawyer Jason Coomer via e-mail message.

Texas Business Litigation Include A Variety of Potential Issues From Business Torts and Breach of Contract to Intellectual Property and Real Estate Disputes

Texas Business Litigation can include a variety of issues including breaches of contract, patent infringement, business fraud, misrepresentation, trade secret theft, breach of fiduciary duty, commercial lease disputes, unfair competition claims, intentional interference with business contracts, shareholder suppression, partnership disputes, and business dissolutions.  Below are some of the more common areas of business litigation:

• Texas Oil Business Litigation Lawyer and Texas Eagle Ford Shale Litigation
• Shareholder Investment Fraud Lawsuits & Shareholder Suppression Lawsuits
• Texas Joint Venture Lawyer and Texas International Joint Venture Lawyer
• Texas Business Franchise Litigation Lawyer
• Business Litigation and Commercial Business to Business Lawyer
• Texas Business Shareholder Action Lawyer
• Eminent Domain, expropriation, condemnation, and public takings
• Architectural Works Copyright Protection Act (AWCPA) Lawsuits
• Real Estate and Investment Fraud Lawsuits
• Real Estate Investment Fraud Lawsuits
• Texas Breach of Contract Lawyer and Texas Breach of Contract Claims
• Texas Eagle Ford Shale Business Tort Lawsuits
• International Patent Infringement & Trade Secret Lawsuits
• Texas Patent Infringement Lawsuits
• Texas Oil Royalty Fraud Lawsuits and Texas Oil Production Fraud Lawyer
• Texas Bank Fraud Lawyer and Texas Loan Fraud Lawsuits
• Investment Fraud, Ponzi Scheme, and Broker Negligence Lawsuits
• Texas Business Investment Fraud Lawsuits
• Texas Business to Business Litigation Trial, Arbitrations, and Mediation
• Texas Corporate Fraud Lawyer and Texas Partnership Fraud Lawyer
• Texas Commercial Real Estate Litigation 
• Texas Business Disputes (Breach of Contract, Theft of Trade Secrets, Fraud)
• Texas Internet Domain Disputes Copyright, Trademark, and Patent Litigation
• Texas Dissolution of Partnerships, Businesses, and Joint Ventures
• Texas Breach of Real Estate Development Contract Lawsuits
• Texas Broker Fraud Lawsuits
• Texas Business Development Lawyer
• Texas Breach of Web Development Contract Lawsuits
• Texas Intellectual Property Lawsuits
• Texas Shareholder Action Lawyer
  

   Recovering Business, Corporate, and Partnership Assets Through Business Fraud Litigation and Corporate Fraud or Partnership Fraud Lawsuits

Protecting corporate and partnership assets including investment capital, mineral rights, intellectual property, water rights, stock, real estate, trade secrets, customer lists, and revenues is an important part of running a successful business.  However, sometimes someone in a position of power or with opportunity will take advantage of a situation to steal or take what does not belong to them.  The first step in recovering the assets is to obtain evidence of the fraudulent act.  Commonly, computer hard drives, e-mail messages, and accounting records are the best source of evidence to prove wrongdoing.  The  second step is to calculate the assets that were taken and any additional damages that this fraud has caused.  The third step is to identify all potential defendants that allowed the fraud to take place and determine what liability and ability to pay each potential defendant has.

In these situations, it is often valuable to have a skilled business litigation team familiar with accounting forensics, computer forensics, asset searches, Federal Law, and Texas law work on investigating and prosecuting corporate fraud lawsuits and partnership fraud lawsuits.  

For more information on this topic,  please feel free to contact Texas Oil Business Fraud Lawyer Jason Coomer via e-mail message.

Sub-Contractor Bounty Actions and Sub-Supplier Whistleblower Reward Lawsuits: Sub-Contractor FCPA Violations and Faulty Component Parts Can Be The Basis of Bounty Actions and Whistleblower Reward Lawsuits by Sub-Contractor Bounty Action Lawyer and Sub-Contractor Whistleblower Reward Lawyer Jason Coomer

Sub-Contractor Bounty Actions and Sub-Supplier Whistleblower Reward Lawsuits: Sub-Contractor FCPA Violations and Sub-Supplier Faulty Component Parts Can Be The Basis of Bounty Actions and Whistleblower Reward Lawsuits by Sub-Contractor Bounty Action Lawyer and Sub-Supplier Whistleblower Reward Lawyer Jason Coomer

Many large corporations including government contractors use sub-contractors and sub-suppliers to produce component parts in aircraft, military weapons systems, computers, medical equipment, pharmaceuticals, and other products.  However, when these sub-contractors and sub-suppliers 1) violate the FCPA, 2) produce faulty component parts, or 3) do business with prohibited parties, the fraud or prohibited act can become the basis of a Bounty Action or Whistleblower Reward Lawsuit for the large corporation.  

If you are aware of Foreign Corrupt Practice Act (FCPA) violations, sub-standard components, or other supply chain prohibited actions, please feel free to contact FCPA Sub-Contractor Bounty Action Lawyer and Sub-Contractor Whistleblower Reward Lawyer, Jason Coomer via e-mail message.  Please also feel free to go to the following web pages for more information on FCPA Bounty Action Lawsuits, International FCPA Bounty Actions, and Whistleblower Reward Lawsuits. 

 FCPA Violations Can Also Be The Basis of Bounty Actions

FCPA violations in the supply chain by sub-contractors and sub-suppliers can also be the basis of Bounty Actions that offer large rewards for persons with original and specialized knowledge of the violations.  These Bounty Actions can disgorge large contracts and be the basis of substantial recoveries for the whistleblower.  Further, recent whistleblower protections now allow whistleblowers to anonymously file bounty actions through a FCPA Bounty Action Lawyer.   

For more information on this issue please feel free to go to the following web pages: FCPA Violations in Pharmaceutical Industry, FCPA Violations in the Oil Industry, FCPA Violations in the Financial Services Industry, and FCPA Violations in the Electronics Industry. 

Faulty Electronic Components Can Be The Basis of FCPA Bounty Actions and Whistleblower Reward Lawsuits

Many electronic components were traditionally manufactured in the United States and Europe, but are now being manufactured in China, Mexico, India, and South America.  When these electronic components are fake or substandard parts, the general government contractor can sometimes be held to have made false certifications regarding the quality of these electronic components.  These false certifications can be the basis of a Qui Tam False Claims Act Whistleblower Reward Lawsuit.  

These lawsuits encourage whistleblowers including international whistleblowers along the electronic component supply chain to blow the whistle on fake military electronic components, low quality electronic components, and other counterfeit electronic parts.

For more information on this issue, please feel free to go to the following web pages: Defense Contractor False Certification Whistleblower Reward Lawsuits, and Military Contractor Fake Part Procurement Fraud Whistleblower Lawsuits.

Pradaxa Lawsuit Information: Excessive Bleeding From Pradaxa Has No Antidote and Can Cause Death by Texas Pradaxa Lawyer Jason Coomer

Pradaxa Lawsuit Information: The Blood Thinner Pradaxa Can Cause Excessive Bleeding and Has No Known Antidote or Reversal Agent Which Can Cause Death in Patients Taking the Blood Thinner by Texas Pradaxa Lawyer Jason Coomer

Pradaxa has been marketed as a new and improved blood thinner to replace existing successful blood thinners.  Pradaxa has the usual side effects and health risks of other blood thinners which includes excessive bleeding.  However, unlike older blood thinners, Pradaxa has two important differences: 

• Pradaxa has no known reversal agent or antidote, and

• There is no standard method with which to measure the anticoagulant effects of Pradaxa.

These key differences can cause persons on Pradaxa to experience a build up or overdose of the drug, excessive bleeding, and ultimately the person's death.  For more information on this topic, please feel free to send an e-mail message to Pradaxa Lawyer, Jason Coomer.

Pradaxa Has Been Marketed As A New And Improved Blood Thinner That Has Been Added To Numerous Hospital Formularies As An Established Blood Thinner Allowing Pradaxa To Rapidly Gain Market Share and Expanding Its Use

Pradaxa (dabigatran etexilate mesylate) is a direct thrombin inhibitor anticoagulant, which became FDA-approved on October 29, 2010. Pradaxa reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Pradaxa is being marketed to be prescribed and used to replace existing successful blood thinners such as Warfarin (Coumadin).  Within the first seven months after Pradaxa's approval, more than 250,000 patients were prescribed Pradaxa.  In July 2011, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) announced that Pradaxa (dabigatran etexilate mesylate) capsules had been added to hospital formularies at 49 of the top 50 cardiology and heart surgery hospitals in the United States.  In other words Pradaxa was added as the blood thinner of choice in formularies that insure about 90 percent of covered lives in the U.S.

Boehringer Ingelheim has successfully marketed Pradaxa as an improvement over other blood thinners.  However, Pradaxa has already led to hundreds of reports of deaths and many other serious life-threatening injuries.

Large Drug Companies That Influence Standards of Care Including Hospital Formularies Through Marketing Fraud and Fraudulent Research Can Be Held Liable For Medicaid Fraud and Medicare Fraud Through Whistleblower Reward Lawsuits

Many health care professions have become aware of the strong influence that drug companies now have in determining community standards of care for medication use in patients.  These drug companies often push drug samples into many hospitals and use powerful forms of manipulation including biased research, influencing key medical doctors, and kickbacks to get their drugs placed on hospital formularies.

Whistleblowers that are the first to file on these fraudulent practices can expose fraud and obtain large whistleblower rewards for exposing fraud. These medical professionals and pharmaceutical professionals can also have a drug formulary fraud whistleblower reward lawyer confidentially review a potential case prior to stepping forward.  For more information on Drug Formulary Fraud Whistleblower Reward Lawsuits, please feel free to go to the following web page: Drug Formulary Fraud Whistleblower Reward Lawsuit.

Pradaxa Lawsuit Information: The Blood Thinner Pradaxa Can Cause Excessive Bleeding and Has No Known Antidote or Reversal Agent Which Can Cause Death in Patients Taking the Blood Thinner

For more information on this topic, please feel free to go to the following web page: Pradaxa Lawsuit Information or please feel free to send an e-mail message to Pradaxa Lawyer, Jason Coomer.

Pharmaceutical Company Fraud: Government and Whistleblowers Seek Billions by Texas Pharmaceutical Fraud Whistleblower Lawyer

Pharmaceutical Company Fraud: Government and Whistle-blowers Have Obtained Over $30 Billion From Large Drug Companies And These Numbers Will Increase As Drug Companies Commit Fraud To Obtain Their Share of the Over $800 Billion Drug Industry Annual Revenues by Pharmaceutical Company Fraud Whistleblower Lawyer Jason S. Coomer

State and Federal governments are cracking down are large pharmaceutical companies that commit fraud and violate the law to obtain large drug procurement contracts.  Under the Federal False Claim Act and State Medicaid Fraud Recovery laws, pharmaceutical companies have been forced to pay over $30 Billion in civil and criminal penalties.  This money has been paid to federal and state governments and whistleblowers.  The penalties are drug companies that have committed illegal and fraudulent activities including fraudulent off label drug marketing practices, fraudulent drug marketing, illegal drug kickbacks, and price fixing. 

Billion dollar fines may seem like a large amount of money to pay in fines that would prevent future illegal actions, however, some drug companies are repeat offenders and plan to continue their fraudulent activities because of the large profits that they can make by violating the law.  Some of these companies have determined that the these fines are the price of doing business. The pharmaceutical industry has total annual revenues of over $800 Billion and this global is increasing as the drug industry continue to expand.  Further, with profits for some drugs of over $100 Billion, it can often be worth it for a pharmaceutical company to commit fraud and violate the law to obtain dominance in a market and obtain large public section contracts that translate into large profits.

Government Fines and Whistle-blower Rewards Will Continue to Increase As State and Federal Governments Seek To Reduce Fraud and The Cost of Medical Care

With several repeat offenders and the need to reduce huge public sector medical costs, several governments will continue to raise the fines as well as increase rewards to those that report large scale pharmaceutical company fraud.  Texas currently leads all states in settlements made possible by private-sector whistle-blowers, but the Federal government and numerous other states have also determined the cracking down on pharmaceutical fraud, Medicare fraud, Medicaid fraud, and other forms of health care fraud are important and a politically viable method of reducing public health care costs.

Pharmaceutical marketing representatives and pharmaceutical professionals that are aware of fraudulent off label drug marketing practices, fraudulent drug marketing, illegal drug kickbacks, or price fixing are encouraged to be the first to expose pharmaceutical company fraud.  By the first to file on pharmaceutical company fraud, a whistle-blower can become eligible for a large financial recovery and can avoid potential liability for failing to expose a know crime.

If you are aware of a pharmaceutical company that is committing pharmaceutical company fraud and would like to confidentially have your potential case reviewed, please feel free to contact Pharmaceutical Company Fraud Whistleblower Lawyer Jason Coomer via e-mail message or please feel free to go to the following web pages on this topic: Whistle-blower Reward Lawsuits, Health Care Fraud Whistle-blower Lawsuits, Pharmaceutical Marketing Fraud Lawsuits, and Hospital Formulary Drug Fraud Lawsuits & Off Label Marketing Fraud Lawsuits. 

Armstrong Fraud Whistleblower Case: Will US Department of Justice Join This Lawsuit? by Whistleblower Recovery Lawyer Jason S. Coomer

Armstrong Fraud Whistleblower Case: The United States Attorney General Is Currently Deciding Whether to Join The Fraud Whistleblower Reward Lawsuit That Has Been Filed Against Lance Armstrong by Whistleblower Recovery Lawyer Jason S. Coomer

Under Federal law, whistleblower recoveries can come through four different whistleblower recovery laws.  The Federal False Claims Act is the oldest of the laws and under this law the Federal Government has brought in approximately $30 Billion.  Under this law successful whistleblowers have been awarded over $3 Billion.  Through this law people that are aware of substantial fraud against the United States are encouraged to expose the fraud and in some cases can receive rewards for exposing fraud.  These whistleblower recovery lawsuits are the most effective method for identifying and preventing large scale fraud against the government, in financial markets, and in large corporations.

In applying whistleblower recovery laws to the Lance Armstrong situation, a qui tam lawsuit was filed in 2010 alleging that the U.S. Postal Service Team defrauded the Postal Service by taking sponsorship money while doping.  Under the Federal False Claims Act, the Attorney General has the option to join the claim or allow the whistleblower to proceed with the case without the United States joining the case.

For more on Whistleblower Recovery Laws, please feel free to go to the following web page: Whistleblower Recovery Laws, and/or read the article cited below:

Attorney General Eric Holder will decide whether to join whistleblower lawsuit against Lance Armstrong - NY Daily News

"Landis filed the whistleblower suit, also known as a “qui tam” suit, against the U.S. Postal Service Team under the False Claims Act, which allows “whistleblowers” to file suit on behalf of the federal government, in 2010. Landis claims the team defrauded the Postal Service by taking sponsorship money — up to $30 million — from the government-funded agency while cyclists were doping. The government could seek as much as $90 million, which would be triple the damages."